TW200822909A - Method for manufacturing bird flu immune egg - Google Patents
Method for manufacturing bird flu immune egg Download PDFInfo
- Publication number
- TW200822909A TW200822909A TW95142518A TW95142518A TW200822909A TW 200822909 A TW200822909 A TW 200822909A TW 95142518 A TW95142518 A TW 95142518A TW 95142518 A TW95142518 A TW 95142518A TW 200822909 A TW200822909 A TW 200822909A
- Authority
- TW
- Taiwan
- Prior art keywords
- egg
- virus
- vaccine
- chicken
- eggs
- Prior art date
Links
- 206010064097 avian influenza Diseases 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims abstract description 11
- 241000700605 Viruses Species 0.000 claims abstract description 64
- 235000013601 eggs Nutrition 0.000 claims abstract description 52
- 229960005486 vaccine Drugs 0.000 claims abstract description 18
- 241000287828 Gallus gallus Species 0.000 claims abstract description 17
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 16
- 210000002966 serum Anatomy 0.000 claims abstract description 14
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 13
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 13
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 239000012530 fluid Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 20
- 208000002979 Influenza in Birds Diseases 0.000 claims description 15
- 241000712461 unidentified influenza virus Species 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 210000003743 erythrocyte Anatomy 0.000 claims description 6
- 230000004520 agglutination Effects 0.000 claims description 5
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 230000004720 fertilization Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 210000001161 mammalian embryo Anatomy 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 210000000601 blood cell Anatomy 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims description 2
- 238000005345 coagulation Methods 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000012491 analyte Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 210000001747 pupil Anatomy 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000000427 antigen Substances 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 206010022000 influenza Diseases 0.000 description 10
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241001440741 CHER virus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000000423 heterosexual effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200822909A true TW200822909A (en) | 2008-06-01 |
| TWI309563B TWI309563B (enExample) | 2009-05-11 |
Family
ID=44770911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW95142518A TW200822909A (en) | 2006-11-17 | 2006-11-17 | Method for manufacturing bird flu immune egg |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW200822909A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894397A (zh) * | 2011-07-27 | 2013-01-30 | 郑长义 | 禽流感免疫鸡蛋生产的方法 |
-
2006
- 2006-11-17 TW TW95142518A patent/TW200822909A/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI309563B (enExample) | 2009-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pensaert et al. | Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man | |
| CN101880651B (zh) | 番鸭细小疫苗的制备方法 | |
| CN101721694B (zh) | 山羊支原体肺炎二联灭活疫苗及其制备方法 | |
| CN104922663A (zh) | 一种鸡新城疫和h9亚型禽流感二联疫苗 | |
| CN103083659A (zh) | 新型无油佐剂制备方法及用途 | |
| CN107050448A (zh) | 一种禽流感病毒、禽腺病毒二联灭活疫苗的制备方法 | |
| CN104258389B (zh) | 一种疫苗组合物及其制备方法和应用 | |
| CN102068695B (zh) | 鸡新城疫、传染性支气管炎、禽流感(h9亚型)、传染性法氏囊病四联灭活疫苗的生产方法 | |
| CN104928259A (zh) | 一种h9亚型禽流感病毒、灭活疫苗及其制备方法 | |
| CN102038949A (zh) | 鸡新城疫、传染性支气管炎、减蛋综合征、禽流感（h9亚型）四联灭活疫苗的生产方法 | |
| CN101843900B (zh) | 一种禽流感灭活疫苗及其制造方法 | |
| CN102302775B (zh) | 鸡新城疫与h9亚型禽流感二联灭活疫苗及其制备方法 | |
| CN105031638A (zh) | 一种鸡新城疫、禽流感和传染性法氏囊三联灭活疫苗 | |
| CN100572532C (zh) | 一种鸭瘟疫苗及其专用毒株 | |
| CA2923026A1 (en) | Nasal mucosal vaccine composition | |
| CN105770892A (zh) | 一种防治鸡心包积液-肝炎综合征生物兽药的制备方法 | |
| CN103495167A (zh) | 一种鸡传染性法氏囊病复合活疫苗的制备方法 | |
| CN106065030B (zh) | 鸡包涵体肝炎的卵黄抗体及其制备方法 | |
| JP6955497B2 (ja) | コクシジウム症ワクチン | |
| TW200822909A (en) | Method for manufacturing bird flu immune egg | |
| CN102166355A (zh) | 一种用于预防鸡疾病的四联灭活疫苗 | |
| Arif et al. | Seroprevalence of avian influenza in broilers of District Quetta, Balochistan, Pakistan | |
| CN103497933B (zh) | 一株h9n2型禽流感毒株在疫苗开发上的应用 | |
| CN105807049B (zh) | 一种鸭坦布苏病毒病血凝抑制试验抗原及其制备方法 | |
| CN101025420B (zh) | 一种禽流感病毒乳胶凝集检测试剂盒及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees | ||
| MM4A | Annulment or lapse of patent due to non-payment of fees |